23rd Conference on Retroviruses and Opportunistic Infections (CROI 2016), 22-25 February 2016, Boston
1 June 2016. Related: Conference reports, Conference index, CROI 23 (Retrovirus) 2016.
Every year, CROI brings more than 5000 researchers, doctors, community activists and other health workers to meet for one of the most scientifically important HIV conferences.
This year the meeting was in Boston and with over 1000 studies presented, there is far more to report than the key studies that make headline news.
This year, major studies present research on basic and clinical science relating to prevention, new treatment and global access.
The programme and abstracts are posted to the conference website, with many posters also available as PDF files.
Although the programme is now online, abstracts are not publically available until after the conference ends.
Webcasts are now also online and were posted very soon after the oral presentations.
Reports in this issue of HTB are:
- No effect of tenofovir on infant bone mineral content in African study
- Use of modelling to predicting paediatric dosing of long acting antiretrovirals
- Nevirapine dosing for treatment of neonates
- START substudies: increased quality of life from earlier treatment but no impact on vascular function or cardiovascular markers
- Six-week ledipasvir/sofosbuvir in HIV positive patients with acute HCV